Human T lymphotropic virus type II infection and humoral responses to pneumococcal polysaccharide and tetanus toxoid vaccines.
Human T lymphotropic virus type II infection and humoral responses to pneumococcal polysaccharide and tetanus toxoid vaccines.
复制标题
人类 T 淋巴细胞病毒 II 型感染和对肺炎球菌多糖和破伤风类毒素疫苗的体液反应。
DOI:
10.1086/428505
复制
发表时间:
2005
期刊:
影响因子:
--
通讯作者:
Murphy,EdwardL
中科院分区:
文献类型:
--
作者:
Jarvis,GaryA;Janoff,EdwardN;Cheng,Hui;Devita,Deborah;Fasching,Claudine;McCulloch,CharlesE;Murphy,EdwardL
Infection with human T lymphotropic virus type II (HTLV-II) has been linked to an increased incidence of bacterial pneumonia. To determine whether HTLV-II infection is associated with impaired humoral immune responses, we immunized a cohort of HTLV-II–infected subjects and matched uninfected control subjects with 23-valent pneumococcal polysaccharide and tetanus toxoid vaccines. The pneumococcal polysaccharide vaccine elicited comparable and significant increases in concentrations of IgG against all 5 serotypes tested at 1 and 6 months after immunization in both groups. The avidity and opsonophagocytic functions of the anticapsular IgG were similar. The concentrations of tetanus toxoid–specific IgG also increased comparably and significantly over time in both groups. Thus, HTLV-II–infected persons develop robust humoral responses to potentially protective polysaccharide and protein vaccines